RT Journal Article
SR Electronic
T1 COVID-19 pandemic: A Hill type mathematical model predicts the US death number and the reopening date
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.12.20062893
DO 10.1101/2020.04.12.20062893
A1 Aboelkassem, Yasser
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.12.20062893.abstract
AB A mathematical model that can be used to estimate the total number of cases and deaths due to COVID-19 pandemic is presented in this study. The parameters and the associated uncertainty in the model are optimized and quantified using various reported data sets reported from different countries. The results suggest that, by the mid of June or early July 2020, the outbreak will strongly decay and the US will have about 800K confirmed cases and less than 50K deaths.Significance Statement This study presents a mathematical model that can be used to estimate the total number of cases and deaths in the US due to COVID-19. The model forecasting about < 800K cases and < 50K total numbers of deaths in the United States. The results suggest that late May or early June, 2020 is probably a good time to end the shutdown order and reopen the country for the daily routine business.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA